|
Oct. 7, 2022 |
Oct. 6, 2022 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
9,117
-22.2%
25.90
236,139
USD
|
9,117
-22.2%
|
25.90
|
236,139
USD
|
|
|
Oct. 7, 2022 |
Oct. 6, 2022 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
20,782
-39.4%
25.90
538,273
USD
|
20,782
-39.4%
|
25.90
|
538,273
USD
|
|
|
Oct. 7, 2022 |
Oct. 6, 2022 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
16,231
-47.9%
25.29
410,508
USD
|
16,231
-47.9%
|
25.29
|
410,508
USD
|
|
|
Oct. 4, 2022 |
Oct. 4, 2022 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
1,280
-6.8%
25.02
32,026
USD
|
1,280
-6.8%
|
25.02
|
32,026
USD
|
|
|
Oct. 4, 2022 |
Oct. 4, 2022 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
223
-0.7%
25.00
5,575
USD
|
223
-0.7%
|
25.00
|
5,575
USD
|
|
|
Oct. 4, 2022 |
Oct. 4, 2022 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
137
-0.4%
25.00
3,425
USD
|
137
-0.4%
|
25.00
|
3,425
USD
|
|
|
Oct. 4, 2022 |
Oct. 3, 2022 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
2,883
-14.0%
25.01
72,107
USD
|
2,883
-14.0%
|
25.01
|
72,107
USD
|
|
|
Oct. 4, 2022 |
Oct. 3, 2022 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
13
-0.0%
25.00
325
USD
|
13
-0.0%
|
25.00
|
325
USD
|
|
|
Oct. 4, 2022 |
Oct. 3, 2022 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
167
-0.5%
25.00
4,175
USD
|
167
-0.5%
|
25.00
|
4,175
USD
|
|
|
Oct. 4, 2022 |
Sept. 30, 2022 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
29,606
-62.6%
25.02
740,757
USD
|
29,606
-62.6%
|
25.02
|
740,757
USD
|
|
|
Oct. 4, 2022 |
Sept. 30, 2022 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
647
-2.0%
25.07
16,221
USD
|
647
-2.0%
|
25.07
|
16,221
USD
|
|
|
Oct. 4, 2022 |
Sept. 30, 2022 |
PS
Planned sale
|
Katkin Keith
Non-Executive Director
|
2,914
-8.3%
25.07
73,056
USD
|
2,914
-8.3%
|
25.07
|
73,056
USD
|
|
|
Sept. 21, 2022 |
Sept. 20, 2022 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
59,649
-77.0%
23.25
1,387,012
USD
|
59,649
-77.0%
|
23.25
|
1,387,012
USD
|
|
|
Sept. 21, 2022 |
Sept. 19, 2022 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
114,339
-86.5%
23.03
2,633,044
USD
|
114,339
-86.5%
|
23.03
|
2,633,044
USD
|
|
|
Sept. 16, 2022 |
Sept. 16, 2022 |
PS
Planned sale
|
Podlesak Dennis
Non-Executive Director
|
6,556
-8.0%
23.43
153,625
USD
|
6,556
-8.0%
|
23.43
|
153,625
USD
|
|
|
Sept. 16, 2022 |
Sept. 16, 2022 |
PS
Planned sale
|
Podlesak Dennis
Non-Executive Director
|
5,419
-6.7%
23.43
126,982
USD
|
5,419
-6.7%
|
23.43
|
126,982
USD
|
|
|
Sept. 16, 2022 |
Sept. 16, 2022 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
53,034
-74.8%
23.22
1,231,423
USD
|
53,034
-74.8%
|
23.22
|
1,231,423
USD
|
|
|
Sept. 16, 2022 |
Sept. 16, 2022 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
71,966
-80.1%
23.22
1,671,015
USD
|
71,966
-80.1%
|
23.22
|
1,671,015
USD
|
|
|
Sept. 16, 2022 |
Sept. 15, 2022 |
PS
Planned sale
|
Podlesak Dennis
Non-Executive Director
|
66,840
-46.9%
24.20
1,617,381
USD
|
66,840
-46.9%
|
24.20
|
1,617,381
USD
|
|
|
Sept. 16, 2022 |
Sept. 15, 2022 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
66,775
-78.9%
24.20
1,616,035
USD
|
66,775
-78.9%
|
24.20
|
1,616,035
USD
|
|
|
Sept. 16, 2022 |
Sept. 14, 2022 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
87,645
-83.1%
23.80
2,085,855
USD
|
87,645
-83.1%
|
23.80
|
2,085,855
USD
|
|
|
Aug. 26, 2022 |
Aug. 24, 2022 |
PS
Planned sale
|
Ordentlich Peter
Chief Scientific Officer
Officer
|
2,154
-89.0%
25.04
53,927
USD
|
2,154
-89.0%
|
25.04
|
53,927
USD
|
|
|
Aug. 26, 2022 |
Aug. 24, 2022 |
PS
Planned sale
|
Ordentlich Peter
Chief Scientific Officer
Officer
|
22,846
-98.9%
25.04
571,966
USD
|
22,846
-98.9%
|
25.04
|
571,966
USD
|
|
|
Aug. 9, 2022 |
Aug. 5, 2022 |
PS
Planned sale
|
Legault Pierre
Non-Executive Director
|
14,000
-30.4%
23.02
322,223
USD
|
14,000
-30.4%
|
23.02
|
322,223
USD
|
|
|
Aug. 9, 2022 |
Aug. 5, 2022 |
PS
Planned sale
|
Legault Pierre
Non-Executive Director
|
10,000
-23.8%
23.02
230,159
USD
|
10,000
-23.8%
|
23.02
|
230,159
USD
|
|
|
July 27, 2022 |
July 25, 2022 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
11,838
-40.1%
21.06
249,254
USD
|
11,838
-40.1%
|
21.06
|
249,254
USD
|
|
|
July 27, 2022 |
July 25, 2022 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
19,764
-52.8%
21.06
416,139
USD
|
19,764
-52.8%
|
21.06
|
416,139
USD
|
|
|
July 8, 2022 |
July 7, 2022 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
100
-0.6%
21.00
2,100
USD
|
100
-0.6%
|
21.00
|
2,100
USD
|
|
|
July 8, 2022 |
July 6, 2022 |
PS
Planned sale
|
Metzger Michael A
Chief Executive Officer
Executive Director
|
15,009
-45.9%
21.07
316,307
USD
|
15,009
-45.9%
|
21.07
|
316,307
USD
|
|
|
July 5, 2022 |
July 1, 2022 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
62,292
-77.7%
19.00
1,183,430
USD
|
62,292
-77.7%
|
19.00
|
1,183,430
USD
|
|
|
April 5, 2022 |
April 4, 2022 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
3,128
-14.9%
18.29
57,220
USD
|
3,128
-14.9%
|
18.29
|
57,220
USD
|
|
|
April 5, 2022 |
April 1, 2022 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
70,545
-79.8%
17.46
1,231,568
USD
|
70,545
-79.8%
|
17.46
|
1,231,568
USD
|
|
|
April 5, 2022 |
April 1, 2022 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
24,500
-57.9%
17.44
427,314
USD
|
24,500
-57.9%
|
17.44
|
427,314
USD
|
|
|
April 5, 2022 |
April 1, 2022 |
PS
Planned sale
|
Morrison Briggs
President, Head of R&D
Executive Director
|
6,000
-12.4%
17.44
104,633
USD
|
6,000
-12.4%
|
17.44
|
104,633
USD
|
|
|
Feb. 3, 2022 |
Feb. 1, 2022 |
S
Sale
|
Nolte Alexander
Chief Accounting Officer
Officer
|
968
-100.0%
16.65
16,117
USD
|
968
-100.0%
|
16.65
|
16,117
USD
|
|
|
Feb. 3, 2022 |
Feb. 1, 2022 |
S
Sale
|
Ordentlich Peter
Chief Scientific Officer
Officer
|
1,412
-100.0%
16.65
23,510
USD
|
1,412
-100.0%
|
16.65
|
23,510
USD
|
|
|
Dec. 22, 2021 |
Dec. 22, 2021 |
PS
Planned sale
|
Legault Pierre
Non-Executive Director
|
24,000
-60.0%
22.01
528,206
USD
|
24,000
-60.0%
|
22.01
|
528,206
USD
|
|
|
Dec. 22, 2021 |
Dec. 20, 2021 |
PS
Planned sale
|
Legault Pierre
Non-Executive Director
|
20,000
-55.6%
21.01
420,250
USD
|
20,000
-55.6%
|
21.01
|
420,250
USD
|
|
|
Dec. 20, 2021 |
Dec. 20, 2021 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
45,000
-71.8%
20.29
912,960
USD
|
45,000
-71.8%
|
20.29
|
912,960
USD
|
|
|
Dec. 20, 2021 |
Dec. 20, 2021 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
16,000
-47.5%
20.29
324,608
USD
|
16,000
-47.5%
|
20.29
|
324,608
USD
|
|
|
Dec. 20, 2021 |
Dec. 17, 2021 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
1,676
-8.7%
19.02
31,877
USD
|
1,676
-8.7%
|
19.02
|
31,877
USD
|
|
|
Dec. 20, 2021 |
Dec. 17, 2021 |
PS
Planned sale
|
Morrison Briggs
Chief Executive Officer
Executive Director
|
35,156
-42.1%
20.00
703,120
USD
|
35,156
-42.1%
|
20.00
|
703,120
USD
|
|
|
Dec. 20, 2021 |
Dec. 16, 2021 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
22,715
-56.3%
19.08
433,400
USD
|
22,715
-56.3%
|
19.08
|
433,400
USD
|
|
|
Dec. 15, 2021 |
Dec. 13, 2021 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
34,564
-66.2%
19.05
658,555
USD
|
34,564
-66.2%
|
19.05
|
658,555
USD
|
|
|
Dec. 15, 2021 |
Dec. 13, 2021 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
2,045
-10.4%
19.05
38,964
USD
|
2,045
-10.4%
|
19.05
|
38,964
USD
|
|
|
Nov. 19, 2021 |
Nov. 18, 2021 |
PS
Planned sale
|
Egros Fabrice
Non-Executive Director
|
30
-0.2%
18.03
541
USD
|
30
-0.2%
|
18.03
|
541
USD
|
|
|
Nov. 19, 2021 |
Nov. 18, 2021 |
PS
Planned sale
|
Egros Fabrice
Non-Executive Director
|
14,000
-46.7%
18.03
252,452
USD
|
14,000
-46.7%
|
18.03
|
252,452
USD
|
|
|
Oct. 27, 2021 |
Oct. 26, 2021 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
16,296
-48.0%
19.20
312,825
USD
|
16,296
-48.0%
|
19.20
|
312,825
USD
|
|
|
Oct. 27, 2021 |
Oct. 25, 2021 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
44,704
-71.7%
19.13
855,335
USD
|
44,704
-71.7%
|
19.13
|
855,335
USD
|
|
|
Sept. 28, 2021 |
Sept. 27, 2021 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
24,437
-58.1%
19.51
476,832
USD
|
24,437
-58.1%
|
19.51
|
476,832
USD
|
|
|
Aug. 20, 2021 |
Aug. 18, 2021 |
PS
Planned sale
|
Egros Fabrice
Non-Executive Director
|
15,635
-49.4%
15.75
246,328
USD
|
15,635
-49.4%
|
15.75
|
246,328
USD
|
|
|
May 20, 2021 |
May 18, 2021 |
PS
Planned sale
|
Egros Fabrice
Non-Executive Director
|
1,683
-9.5%
18.65
31,385
USD
|
1,683
-9.5%
|
18.65
|
31,385
USD
|
|
|
May 20, 2021 |
May 18, 2021 |
PS
Planned sale
|
Egros Fabrice
Non-Executive Director
|
11,926
-40.3%
18.65
222,398
USD
|
11,926
-40.3%
|
18.65
|
222,398
USD
|
|
|
April 28, 2021 |
April 26, 2021 |
B
Purchase
|
Meyers Michael L.
SVP, Chief Medical Officer
Officer
|
500
+3.3%
15.46
7,730
USD
|
500
+3.3%
|
15.46
|
7,730
USD
|
|
|
April 22, 2021 |
April 22, 2021 |
B
Purchase
|
Podlesak Dennis
Non-Executive Director
|
13,967
+47.6%
14.11
197,077
USD
|
13,967
+47.6%
|
14.11
|
197,077
USD
|
|
|
March 3, 2021 |
March 1, 2021 |
PS
Planned sale
|
Egros Fabrice
Non-Executive Director
|
74
-0.5%
24.31
1,799
USD
|
74
-0.5%
|
24.31
|
1,799
USD
|
|
|
March 3, 2021 |
March 1, 2021 |
PS
Planned sale
|
Egros Fabrice
Non-Executive Director
|
10,167
-38.7%
24.31
247,182
USD
|
10,167
-38.7%
|
24.31
|
247,182
USD
|
|
|
Feb. 10, 2021 |
Feb. 8, 2021 |
PS
Planned sale
|
Morrison Briggs
Chief Executive Officer
Executive Director
|
35,156
-42.1%
20.55
722,403
USD
|
35,156
-42.1%
|
20.55
|
722,403
USD
|
|
|
Feb. 3, 2021 |
Feb. 1, 2021 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
15,000
-45.9%
20.19
302,799
USD
|
15,000
-45.9%
|
20.19
|
302,799
USD
|
|
|
Dec. 3, 2020 |
Dec. 1, 2020 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
15,000
-45.9%
22.97
344,513
USD
|
15,000
-45.9%
|
22.97
|
344,513
USD
|
|
|
Nov. 25, 2020 |
Nov. 23, 2020 |
S
Sale
|
Ordentlich Peter
Chief Scientific Officer
Officer
|
16,334
-100.0%
22.89
373,924
USD
|
16,334
-100.0%
|
22.89
|
373,924
USD
|
|
|
Nov. 25, 2020 |
Nov. 23, 2020 |
S
Sale
|
Ordentlich Peter
Chief Scientific Officer
Officer
|
7,954
-32.7%
23.58
187,594
USD
|
7,954
-32.7%
|
23.58
|
187,594
USD
|
|
|
Nov. 25, 2020 |
Nov. 23, 2020 |
S
Sale
|
Ordentlich Peter
Chief Scientific Officer
Officer
|
5,684
-19.0%
23.33
132,603
USD
|
5,684
-19.0%
|
23.33
|
132,603
USD
|
|
|
Nov. 12, 2020 |
Nov. 10, 2020 |
S
Sale
|
Morrison Briggs
Chief Executive Officer
Executive Director
|
17,466
-27.3%
20.06
350,312
USD
|
17,466
-27.3%
|
20.06
|
350,312
USD
|
|
|
Nov. 12, 2020 |
Nov. 9, 2020 |
S
Sale
|
Morrison Briggs
Chief Executive Officer
Executive Director
|
62,938
-57.5%
20.04
1,261,265
USD
|
62,938
-57.5%
|
20.04
|
1,261,265
USD
|
|
|
Nov. 6, 2020 |
Nov. 4, 2020 |
PS
Planned sale
|
Metzger Michael A
President and COO
Executive Director
|
100,000
-85.0%
20.31
2,031,410
USD
|
100,000
-85.0%
|
20.31
|
2,031,410
USD
|
|
|
Feb. 5, 2020 |
Feb. 4, 2020 |
B
Purchase
|
Morrison Briggs
Chief Executive Officer
|
12,500
+39.8%
8.00
100,000
USD
|
12,500
+39.8%
|
8.00
|
100,000
USD
|
|
|
Oct. 11, 2019 |
Oct. 10, 2019 |
B
Purchase
|
Morrison Briggs
Chief Executive Officer
|
11,000
+53.9%
5.40
59,400
USD
|
11,000
+53.9%
|
5.40
|
59,400
USD
|
|
|
May 13, 2019 |
May 13, 2019 |
B
Purchase
|
Morrison Briggs
Chief Executive Officer
|
7,200
+54.5%
7.29
52,517
USD
|
7,200
+54.5%
|
7.29
|
52,517
USD
|
|
|
May 13, 2019 |
May 9, 2019 |
B
Purchase
|
Morrison Briggs
Chief Executive Officer
|
13,200
+inf%
7.56
99,726
USD
|
13,200
+inf%
|
7.56
|
99,726
USD
|
|
|
March 22, 2019 |
March 21, 2019 |
B
Purchase
|
Meyers Michael L.
SVP, Chief Medical Officer
|
104
+1.5%
4.87
506
USD
|
104
+1.5%
|
4.87
|
506
USD
|
|
|
March 22, 2019 |
March 21, 2019 |
B
Purchase
|
Meyers Michael L.
SVP, Chief Medical Officer
|
1,000
+16.3%
4.93
4,930
USD
|
1,000
+16.3%
|
4.93
|
4,930
USD
|
|
|
Nov. 7, 2018 |
Oct. 30, 2018 |
PP
Planned purchase
|
Meyers Michael L.
SVP, Chief Medical Officer
|
200
+9.1%
4.79
958
USD
|
200
+9.1%
|
4.79
|
958
USD
|
|
|
April 3, 2018 |
April 3, 2018 |
PS
Planned sale
|
Ordentlich Peter
Chief Scientific Officer
|
7,500
-100.0%
15.00
112,500
USD
|
7,500
-100.0%
|
15.00
|
112,500
USD
|
|
|
May 19, 2017 |
May 17, 2017 |
PS
Planned sale
|
Ordentlich Peter
Chief Scientific Officer
|
5,000
-100.0%
15.00
75,000
USD
|
5,000
-100.0%
|
15.00
|
75,000
USD
|
|
